Family Medicine · Slingerlands, NY
NPI
1003905480
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1499 New Scotland Rd
Slingerlands, NY, 12159
Phone (518) 320-7517
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
793 services
Medicare patients, 2024
199
Average age 75
Drug cost, 2024
$646K
5,812 prescriptions
Company payments, 2025
$1,562
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter H Forman was code 99213 (office e&m - established), 137 times for 96 patients. In total Peter H Forman billed 793 services in 28 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 137 | 96 | $55.92 | $7,661 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 130 | 130 | $123.20 | $16K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 120 | 120 | $17.86 | $2,143 |
| G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes | Office | 117 | 112 | $12.76 | $1,493 |
| 99214 Office E&M - Established | Office | 83 | 60 | $87.87 | $7,293 |
| G0008 Administration of influenza virus vaccine | Office | 40 | 40 | $29.61 | $1,185 |
| 90662 Vaccine Product | Office | 38 | 38 | $81.30 | $3,089 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 37 | 36 | $14.70 | $544 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 13 | 13 | $166.60 | $2,166 |
By year: 2022 $29K for 743 services; 2023 $37K for 558 services; 2024 $45K for 793 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter H Forman prescribed most often to Medicare patients was Atorvastatin Calcium, with 393 prescriptions and refills. In total Peter H Forman wrote 5,812 Medicare prescriptions that cost $646K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 393 | 1,062 | 124 | $4,630 |
| Omeprazole Generic | 292 | 721 | 77 | $4,184 |
| Lisinopril Generic | 268 | 711 | 76 | $1,657 |
| Levothyroxine Sodium Generic | 226 | 645 | 62 | $3,782 |
| Losartan Potassium Generic | 182 | 412 | 44 | $1,705 |
| Simvastatin Generic | 161 | 440 | 44 | $1,576 |
| Citalopram Hbr Citalopram Hydrobromide | 157 | 309 | 40 | $846 |
| Metformin Hcl Generic | 129 | 309 | 33 | $841 |
| Metoprolol Succinate Generic | 119 | 281 | 29 | $1,344 |
| Amlodipine Besylate Generic | 118 | 326 | 40 | $373 |
| Farxiga Dapagliflozin Propanediol | 111 | 179 | 26 | $100K |
| Escitalopram Oxalate Generic | 101 | 256 | 25 | $1,394 |
| Duloxetine Hcl Generic | 98 | 164 | 17 | $1,592 |
| Tamsulosin Hcl Generic | 96 | 244 | 29 | $1,598 |
| Hydrochlorothiazide Generic | 79 | 203 | 23 | $370 |
Brand drugs: 731 claims; generic drugs: 5,041 claims; opioid claims: 213.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter H Forman $1,562 ($1,562 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $360.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 11 | $360 |
| Novo Nordisk Inc NVO | 12 | $305 |
| Gilead Sciences, Inc. GILD | 4 | $192 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $125 |
| Kyowa Kirin, Inc. 4151.T | 3 | $84.46 |
| GlaxoSmithKline, LLC. GSK | 3 | $59.86 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $51.68 |
| Exact Sciences Corporation EXAS | 2 | $45.62 |
| Pfizer Inc. PFE | 2 | $45.6 |
| Abbvie Inc. ABBV | 2 | $42.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.